A Review of Antibiotic Use in Pregnancy

Citations Over TimeTop 10% of 2015 papers

Abstract

During pregnancy, untreated sexually transmitted or urinary tract infections are associated with significant morbidity, including low birth weight, preterm birth, and spontaneous abortion. Approximately one in four women will be prescribed an antibiotic during pregnancy, accounting for nearly 80% of prescription medications in pregnant women. Antibiotic exposures during pregnancy have been associated with both short-term (e.g., congenital abnormalities) and long-term effects (e.g., changes in gut microbiome, asthma, atopic dermatitis) in the newborn. However, it is estimated that only 10% of medications have sufficient data related to safe and effective use in pregnancy. Antibiotics such as beta-lactams, vancomycin, nitrofurantoin, metronidazole, clindamycin, and fosfomycin are generally considered safe and effective in pregnancy. Fluoroquinolones and tetracyclines are generally avoided in pregnancy. Physiologic changes in pregnancy lead to an increase in glomerular filtration rate, increase in total body volume, and enhanced cardiac output. These changes may lead to pharmacokinetic alterations in antibiotics that require dose adjustment or careful monitoring and assessment.

Related Papers

• → Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women(2023)1 cited
• → To compare empirical treatment of uncomplicated UTI in pregnancy(2018)
• → Determination of nitrofurantoin and fosfomycin susceptibility among urinary Escherichia coli isolates(2020)
• → COMPARATIVE ASSESSMENT OF FOSFOMYCIN AND NITROFURANTOIN THERAPY IN URINARY TRACT INFECTION DURING PREGNANCY.(2021)
• → Urinary Tract Infection and Antibiotic Sensitivity to Culture Most Commonly to Nitrofurantoin and Fosfomycin(2022)